ProPhase Labs Inc (PRPH)
4.71
-0.24
(-4.85%)
USD |
NASDAQ |
Apr 26, 16:00
4.76
+0.05
(+1.06%)
After-Hours: 20:00
ProPhase Labs Revenue (Quarterly): 3.499M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.499M |
| September 30, 2023 | 8.365M |
| June 30, 2023 | 13.22M |
| March 31, 2023 | 19.30M |
| December 31, 2022 | 21.82M |
| September 30, 2022 | 24.20M |
| June 30, 2022 | 29.09M |
| March 31, 2022 | 47.53M |
| December 31, 2021 | 45.16M |
| September 30, 2021 | 9.472M |
| June 30, 2021 | 9.142M |
| March 31, 2021 | 15.27M |
| December 31, 2020 | 5.163M |
| September 30, 2020 | 3.84M |
| June 30, 2020 | 3.623M |
| March 31, 2020 | 1.888M |
| December 31, 2019 | 3.141M |
| September 30, 2019 | 2.766M |
| June 30, 2019 | 1.651M |
| March 31, 2019 | 2.318M |
| December 31, 2018 | 4.093M |
| September 30, 2018 | 2.439M |
| June 30, 2018 | 3.186M |
| March 31, 2018 | 3.407M |
| December 31, 2017 | 4.151M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.04M |
| June 30, 2017 | 1.905M |
| March 31, 2017 | 0.771M |
| December 31, 2016 | 0.767M |
| September 30, 2016 | 1.402M |
| June 30, 2016 | 1.021M |
| March 31, 2016 | 1.016M |
| December 31, 2015 | -9.923M |
| September 30, 2015 | 4.39M |
| June 30, 2015 | 2.191M |
| March 31, 2015 | 5.86M |
| December 31, 2014 | 8.972M |
| September 30, 2014 | 5.13M |
| June 30, 2014 | 1.797M |
| March 31, 2014 | 6.171M |
| December 31, 2013 | 9.602M |
| September 30, 2013 | 5.949M |
| June 30, 2013 | 1.939M |
| March 31, 2013 | 7.542M |
| December 31, 2012 | 9.078M |
| September 30, 2012 | 5.415M |
| June 30, 2012 | 1.894M |
| March 31, 2012 | 6.018M |
| December 31, 2011 | 7.461M |
| September 30, 2011 | 5.083M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.651M
Minimum
Jun 2019
47.53M
Maximum
Mar 2022
14.11M
Average
9.142M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Fonar Corp | 25.39M |
| XWELL Inc | 7.403M |
| Applied DNA Sciences Inc | 0.8912M |
| Veracyte Inc | 98.20M |
| OncoCyte Corp | 0.314M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.751M |
| Total Expenses (Quarterly) | 14.85M |
| EPS Diluted (Quarterly) | -0.51 |
| Enterprise Value | 90.51M |
| Gross Profit Margin (Quarterly) | -87.34% |
| Profit Margin (Quarterly) | -250.1% |
| Earnings Yield | -20.81% |
| Normalized Earnings Yield | -20.81 |